The biotech bi-weekly: preserving biodiversity, engineering phage therapies, manufacturing difficult-to-express molecules and revolutionizing viticulture

We’ve been bouncing between the lab, the field and the clinic over the last two weeks; here are the latest biotech industry updates! A grant has been awarded to advance research on stem-cell reprogramming in wild animal species, a phage-engineering technology demonstrated toxin-neutralizing effects in a colorectal cancer model, a cell line platform has been launched to help develop difficult-to-express molecules, and a collaboration is utilizing genomics to breed better varieties of grapevines and hops that are resistant to pests and diseases. Plus, so much more! Products Expanding an iPSC-derived portfolio for hematopoietic research Trailhead Biosystems (OH, USA), a biotechnology...